INNOVO: Non-Invasive Wearable to Treat Stress Urinary Incontinence in Women

INNOVO is an FDA-cleared non-invasive wearable to treat Stress Urinary Incontinence in women.

Image: INNOVO (PR News photo)

INNOVO is an FDA-cleared non-invasive wearable to treat Stress Urinary Incontinence (SUI) in women. Developed by Atlanta Therapeutics, INNOVO sends targeted and pain-free muscle stimulations through a pair of shorts, via neuromuscular electrical stimulation (NMES), to safely and effectively strengthen the muscles in the pelvic floor.

Related Femtech Hardware Elvie Partners with NHS to Tackle Stress Urinary Incontinence

“’OMG. I just free’d myself!’ Today, 20 million women in America will rewrite that whispered, uncomfortable admission of bladder weakness1 into a declarative, celebratory shout thanks to INNOVO®, said the company in a press release.

The INNOVO thigh-length, elasticized therapeutic shorts are outfitted with eight electrodes sewn in a crisscross formation across the pelvic region. When activated via its attached hand-held controller, INNOVO delivers a series of pelvic stimulations equivalent to Kegel exercises for strengthening the pelvic floor.

“INNOVO can help women declare freedom from incontinence and independence from pads,” said Dr. Nita Landry, board-certified OB/GYN and co-host of the Emmy® Award-winning television show “The Doctors.”  “These innovative, therapeutic shorts with targeted muscle stimulations empower women to treat the source for a long-term solution, rather than rely on a short-term pad to manage the problem.”

Image: INNOVO

According to the Urology Care Foundation, one in three (20 million) women suffer from SUI at some point in their life. Of those women, 23 percent report it negatively impacts their sex lives and 31 percent dress differently because of their symptoms. Of the 33 percent of women who experience SUI after childbirth, 65 percent are still affected over the next dozen years.

Related DFree Wearable Device for Urinary Incontinence Launches in US

Women can use the device in the privacy and comfort of their home while either standing, reclining or lying down. The recommended treatment is 30-minutes a day, five days a week, for three months. After the three-month period, it is recommended that INNOVO be used once a week for 30-minutes. In each 30-minute session, INNOVO delivers 180 perfect pelvic floor stimulations (or Kegels).

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Sam Draper
June 7, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Gartner For the First Time Lists Resco in its Magic Quadrant for Mobile App Development Platforms

Resco in MADP provides mobile solutions for Microsoft Dynamics 365/CRM and Salesforce.

PainQ: Home Wearable Pain Management System

PainQ for pain management and CobiQ for rhinitis management are two primary products of Hexainnoheal

NFL and Amazon Launch AI Challenge to Crowdsource Ways to Automate Player Identification Using NFL Game Footage

The National Football League (NFL) and Amazon Web Services (AWS) today launched a new artificial ...

Fitbit Taken To Court By Australian Consumer Watchdog

Fitbit has been sued by the ACCC for misleading customers.
Discover more